View Author
cancer prostate prostate cancer screening biopsy study patient marker antigen tumor level result disease breast cohort value serum erspc breast cancer group trial detection analysis panel model assay treatment prostate-speci fic antigen therapy kallikrein diagnosis european control research prostate-specific antigen recommendation number velocity stage rotterdam table sensitivity outcome round prognostic randomized measurement psa velocity testicular prostate cancer screening colorectal cancer oncol prostate-specific chemotherapy tumor markers evidence european randomized study guideline prostate biopsy center concentration follow-up testing prognosis death prostate-speci carcinoma monitoring colorectal method factor report university tissue control arm mortality incidence american roobol mutation
10 Most Recent Publications
|
Screening for prostate cancer: Early detection or overdetection?
(Article)
Vickers, A.J. Roobol, M.J. Lilja, H. |
2012-01-23
|
|
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: Preliminary analysis of the results of the IMPACT study
(Article)
Mitra, A. Bancroft, E. Evans, D.G. Cruger, D. Blanco, I. Mercer, C. Kirk, J. Maehle, L. Hodgson, S. Walker, L. Izatt, L. Douglas, F. Barbachano, Y. Tucker, K. Dorkins, H. Clowes, V. Male, A. Donaldson, A. Brewer, C. Doherty, R. Bulman, B. Osther, P.J. Salinas, M. Page, E. Eccles, D. Axcrona, K. Jobson, I. Newcombe, B. Cybulski, C. Flesch-Janys, D. Buys, S.S. Townshend, S. Friedman, E. Domchek, S.M. Foster, C.S. Ramon Y Cajal, T. Spigelman, A. Teo, S.-H. Nicolai, N. Aaronson, N.K. Ardern-Jones, A. Bangma, C.H. Dearnaley, D. Eyfjord, J. Falconer, A. Jameson, C. Grönberg, H. Hamdy, F. Johannsson, O.T. Khoo, V. Kote-Jarai, Z. Lilja, H. Lubinski, J. Melia, J. Moynihan, C. Peock, S. Mitchell, G. Rennert, G. Schröder, F.H. Sibley, P. Suri, M. Wilson, P. Bignon, Y.-J. Strom, S. Tischkowitz, M. Liljegren, A. Ilencikova, D. Lindeman, G.J. Abele, A. Kyriacou, K. Asperen, C.J. van Kiemeney, L. Easton, D.F. Eeles, R. Stapleton, A. Suthers, G. |
2011-01-01
|
|
On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer
(Article)
Bangma, C.H. Schaik, R.H.N. van Blijenberg, B.G. Roobol, M.J. Lilja, H. Stenman, U-H. |
2010-11-01
|
|
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy
(Article)
Vickers, A.J. Wolters, T. Lilja, H. Savage, C.J. Cronin, A.M. O'Brien, M.F. Roobol, M.J. Aus, G. Scardino, P.T. Hugosson, J. Schröder, F.H. |
2010-09-01
|
|
The relationship between prostate-specific antigen and prostate cancer risk: The prostate biopsy collaborative group
(Article)
Vickers, A.J. Cronin, A.M. Parekh, D.J. Ankerst, D. Bartsch, G. Klocker, H. Horninger, W. Benchikh, A. Salama, G. Villers, A. Freedland, S.J. Moreira, D.M. Roobol, M.J. Schröder, F.H. Lilja, H. Hugosson, J. Jones, J.S. Kattan, M.W. Klein, E. Hamdy, F. Neal, D. Donovan, J. |
2010-09-01
|
|
A four-kallikrein panel for the prediction of repeat prostate biopsy: Data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
(Article)
Gupta, A. Roobol, M.J. Savage, C.J. Peltola, M. Pettersson, K. Scardino, P.T. Vickers, A.J. Schröder, F.H. Lilja, H. |
2010-08-01
|
|
A four-kallikrein panel predicts prostate cancer in men with recent screening: Data from the european randomized study of screening for prostate cancer, Rotterdam
(Article)
Vickers, A.J. Cronin, A.M. Roobol, M.J. Savage, C.J. Peltola, M. Pettersson, K. Scardino, P.T. Schröder, F.H. Lilja, H. |
2010-06-15
|
|
Prostate-Specific Antigen Velocity for Early Detection of Prostate Cancer: Result from a Large, Representative, Population-based Cohort
(Article)
Vickers, A.J. Wolters, T. Schröder, F.H. Lilja, H. Savage, C.J. Cronin, A.M. O'Brien, M.F. Pettersson, K. Roobol, M.J. Aus, G. Scardino, P.T. Hugosson, J. |
2009-11-01
|
|
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen-Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)
(Article)
Roobol, M.J. Kerkhof, M. Lujan, M. Lilja, H. Zappa, M. Denis, L.J. Recker, F. Berenguer, A. Ruutu, M. Kujala, P.M. Bangma, C.H. Aus, G. Schröder, F.H. Tammela, T.L. Villers, A. Rébillard, X. Moss, S.M. Koning, H.J. de Hugosson, J. Auvinen, A. Cuzick, J. Sasieni, P. Hakama, M. Stenman, U.H. Ciatto, S. Nelen, V. Kwiatkowski, M. |
2009-10-01
|
|
Test sensitivity in the European prostate cancer screening trial: Results from Finland, Sweden, and the Netherlands
(Article)
Auvinen, A. Raitanen, J. Moss, S.M. Koning, H.J. de Hugosson, J. Tammela, T.L. Roobol, M.J. Lilja, H. Hakama, M. |
2009-07-01
|
